Jump to content

Vascular-targeting agent

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Rod57 (talk | contribs) at 06:53, 14 December 2008 (join lines). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

A vascular-targeting agent (VTA) or vascular disrupting agent (VDA) is a drug designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis.[1]

VTAs can be small-molecule or ligand-based.

Small-molecule VTAs include :

References

  1. ^ http://clincancerres.aacrjournals.org/cgi/reprint/10/2/415.pdf "Vascular Targeting Agents as Cancer Therapeutics" 2004